US FDA approves Istodax to treat rare form of cancer
Wednesday, November 11, 2009 16:00 IST Maryland
The US Food and Drug Administration has approved Istodax (romidepsin), an injectable medication, for treatment of patients with a rare form of cancer known as Cutaneous T-cell Lymphoma (CTCL).